Tom McLellan, Chief Executive Officer, Treatment Research Institute, and perhaps the most internationally renowned substance use researcher, discussed three separate SBIRT-type projects that the Treatment Research Institute (TRI) has engineered to mesh with the specific cultures and workflows of health settings so that SBIRT creates value and minimizes hassles. Tom did not report randomized controlled trials, but rather a series of formative evaluations. Three scenarios described: 1) SBIRT in the breast cancer ward of a university medical center; 2) SBIRT in middle and high schools in NYC; and 3) Brief interventions (screening not necessary) for seriously addicted, repeat hospital utilizers at the time of discharge – helping to reduce rapid rehospitalizations. McLellan’s presentation was provocative, thought provoking and stimulating.
Presenters: David Mineta, Deputy Director for Demand Reduction, Office of National Drug Control Policy & Tom McLellan, Chief Executive Officer, Treatment Research Institute
CE Credit and Certificate: CE credit for this webinar has expired and is no longer available.